CD30 in Cutaneous Pathology-Reference-Cited by-同舟云学术

CD30 in Cutaneous Pathology

Published:2023-09 Issue:9 Volume:45 Page:593-607
ISSN:0193-1091
Container-title:The American Journal of Dermatopathology
language:en
Short-container-title:

Author:

Fernandez-Flores Angel¹²³^ORCID,Cassarino David⁴

Affiliation:

1. Dermatopathologist, Department of Histopathology, University Hospital El Bierzo, Ponferrada, Spain;

2. Department of Cellular Pathology, Hospital de la Reina, Ponferrada, Spain;

3. Research Department, Institute for Biomedical Research of a Coruña (INIBIC), University of a Coruña (UDC), A Coruña, Spain; and

4. Pathologist, Los Angeles Medical Center (LAMC), Southern California Kaiser Permanente, Departments of Pathology and Dermatology, Los Angeles, CA

Abstract

Abstract: The discovery of CD30 as a diagnostic marker was essential in the identification of not only some lymphomas but also many other solid tumors and benign reactive conditions. Many CD30+ cutaneous disorders and tumors have been categorized since the identification of the marker. With the design of targeted therapies against CD30+ tumoral cells, the interest in CD30 determination was not only diagnostic but also mainly therapeutic. In this article, we explore the historical aspects of the discovery of CD30 and examine the main CD30-related cutaneous pathology, susceptible of anti-CD30 modern treatments.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Dermatology,General Medicine,Pathology and Forensic Medicine

Reference130 articles.

1. Lymphoid cell lines: in vitro cell markers in correlation to tumorigenicity in nude mice;Diehl;Haematol Blood Transfus.,1977

2. The significance of chromosomal findings for the differentiation between lymphoma and lymphoblastoid cell lines;Hellriegel;Haematol Blood Transfus.,1977

3. Establishment of peripheral lymphoid cell cultures from patients with Hodgkin's disease depending on Epstein-Barr-Virus-reactivity and cellular immunity;Diehl;Blut,1977

4. [Epstein-Barr virus (EBV) in lymphoid cells--a human tumor virus?];Diehl;Med Welt.,1977

5. Establishment of a malignant, Epstein-Barr-virus (EBV)-negative cell-line from the pleura effusion of a patient with Hodgkin's disease;Schaadt;Blut,1979